首页|Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)

Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)

扫码查看
The World Health Organization (WHO) has set the goal of eliminating hepatitis as a threat to public health by 2030. Blocking mother-to-child transmission (MTCT) of hepatitis B virus (HBV) is not only the key to eliminating viral hepatitis, but also a hot issue in the field of hepatitis B prevention and treatment. To standardize the clinical management of pre-venting MTCT of HBV and achieve zero HBV infection among infants, the Chinese Foundation for Hepatitis Prevention and Control organized experts to compile a management algorithm for prevention of MTCT of HBV based on the lat-est research progress and guidelines, including 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immuniza-tion are its core components.

Hepatitis BMother-to-child transmissionAlgorithm

Zhihua Liu、Zhongdan Chen、Fuqiang Cui、Yang Ding、Yunfei Gao、Guorong Han、Jidong Jia、Jie Li、Zengde Li、Yingxia Liu、Qing Mao、Ailing Wang、Wei Wang、Lai Wei、Jianhong Xia、Qing Xie、Xizhong Yang、Xueru Yin、Hua Zhang、Liaoyun Zhang、Wenhong Zhang、Hui Zhuang、Xiaoguang Dou、Jinlin Hou

展开 >

Department of Infectious Diseases,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong,China

World Health Organization,Office of the WHO Representative in China,Beijing,China

School of Public Health,Peking Univer-sity,Beijing,China

Department of Infectious Diseases,Shengjing Hospital,China Medical University,Shenyang,Liaoning,China

Department of Gynecology and Obstetrics,Zengcheng Branch of Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong,China

Department of Gynecology and Obstetrics,The Second Affiliated Hospital of the Southeast University,Nanjing,Jiangsu,China

Liver Research Center,Beijing Friendship Hospital,Capital Medical University,Beijing,China

School of Basic Medical Sciences,Peking University Health Science Center,Beijing,China

Chinese Foundation for Hepatitis Prevention and Control,Beijing,China

The Third People's Hospital of Shenzhen,Shenzhen,Guangdong,China

Department of Infectious Diseases,Southwest Hospital,Army Medical University,Chongqing,China

National Centerfor Women and Children's Health,China CDC,Beijing,China

Department of Health Care,Shenzhen Baoan Women's and Children's Hospital,Shenzhen,Guangdong,China

Beijing Tsinghua Changgung Hospital,School of Clinical Medicine,Tsinghua University,Beijing,China

Guangdong Maternal and Child Health Hospital,Guangzhou,Guangdong,China

Department of Infectious Diseases,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai,China

Department of Gynecology and Obstetrics,Beijing Youan Hospital,Capital Medical University,Beijing,China

Depart-ment of Infectious Diseases,First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China

Department of Infectious Diseases,Huashan Hospital,Fudan University,Shanghai,China

展开 >

国家自然科学基金Sanming Project of Medi-cine in Shenzhen

81673243SZSM201911001

2022

临床与转化肝病杂志(英文版)

临床与转化肝病杂志(英文版)

ISSN:
年,卷(期):2022.10(5)
  • 5